RVL Pharmaceuticals plc (RVLPQ)

RVL Pharmaceuticals Revenue

RVL Pharmaceuticals had revenue of $36.92M in the twelve months ending June 30, 2023, with 5.64% growth year-over-year. Revenue in the quarter ending June 30, 2023 was $8.26M, a -2.25% decrease year-over-year. In the year 2022, RVL Pharmaceuticals had annual revenue of $49.72M with 184.10% growth.

• Revenue (ttm): $36.92M
• Revenue Growth: +5.64%
• P/S Ratio: n/a
• Revenue / Employee: $295,352
• Employees: 125
• Market Cap: 111.00 USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	49.72M	32.22M	184.10%
Dec 31, 2021	17.50M	-10.26M	-36.96%
Dec 31, 2020	27.76M	-212.27M	-88.43%
Dec 31, 2019	240.03M	-23.67M	-8.98%
Dec 31, 2018	263.70M	17.95M	7.31%
Dec 31, 2017	245.75M	27.29M	12.49%
Dec 31, 2016	218.46M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.